Recruiting studies: Margin Tumor Free

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)
Phase N/A · 2 location(s) · Avant Health LLC · NCT07657988 A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSm
NA · 6 location(s) · Dentsply Sirona Implants and Consumables · NCT07290790 CD70-targeted immunoPET Imaging of Kidney Cancer
Phase 2 · 1 location(s) · RenJi Hospital · NCT06680089 Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Phase 1 · 7 location(s) · Sairopa B.V. · NCT05856981 Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Phase 2 · 137 location(s) · National Cancer Institute (NCI) · NCT05112601 Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Ce
Phase 1 · 11 location(s) · Neomorph, Inc · NCT07300241 Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06065462 VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Phase 2 · 1 location(s) · Mayo Clinic · NCT07510334 Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the
NA · 20 location(s) · Institut Claudius Regaud · NCT03967834 CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
Phase 2 · 5 location(s) · Jinling Hospital, China · NCT07615348 A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
Phase 2 · 2 location(s) · Stephanie Berg · NCT07123090 Microplastic Exposure From Clear Aligner Wear (MPE)
Phase N/A · 1 location(s) · University of North Carolina, Chapel Hill · NCT06934603 Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07023432 Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07062549 CLEAR-AS: CT-FFR-Guided Revascularization in Patients With Severe Aortic Stenosis
NA · 1 location(s) · Yan'an Affiliated Hospital of Kunming Medical University · NCT07469371 Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Phase 2 · 3 location(s) · Priscilla Hsue, MD · NCT05488431 Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05155033 Aspiration Thrombectomy Using the Symphony or Prodigy System
Phase N/A · 8 location(s) · Imperative Care, Inc. · NCT07350499 Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT07226544 Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07187778 Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer Undergoing Ultra-Low Anterior
NA · 3 location(s) · Tongji Hospital · NCT07605611 Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
Phase 2 · 12 location(s) · Alphyn Biologics · NCT06855745 An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cel
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT06447103 GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound
Phase N/A · 1 location(s) · Medical University of South Carolina · NCT07251803 NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and S
Phase 1/Phase 2 · 7 location(s) · St. Jude Children's Research Hospital · NCT06239272 Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica
Phase 1/Phase 2 · 128 location(s) · Pfizer · NCT07227415 Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabo
Phase 2 · 582 location(s) · National Cancer Institute (NCI) · NCT03866382 Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
Phase 3 · 5 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT07197580 Clinical Evaluation of Customized Attachment Composites in Clear Aligner Therapy
Phase N/A · 1 location(s) · Saglik Bilimleri Universitesi · NCT07261735 Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma
Phase 2 · 1 location(s) · Fudan University · NCT06211790

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.